Impaired fasting glucose levels in overweight or obese subjects for screening of type 2 diabetes in Korea
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background/Aims: We examined the concordance rate among fasting plasma glucose (FPG), 2-hour post-challenge glucose (2hr PG), and hemoglobin A1c (HbA1c) in the diagnosis of diabetes in a population with a high-risk for type 2 diabetes mellitus (T2DM) in Korea. Methods: Among the participants from the Korean Diabetes Prevention Study, individuals with FPG ≥ 100 mg/dL, body mass index (BMI) ≥ 23.0 kg/m2, and no previous history of T2DM were consecutively enrolled after a 75 g glucose tolerance test. We analyzed the differences in the clinical characteristics in subjects with stage 1 (FPG, 100 to 109 mg/dL) and stage 2 (FPG, 110 to 125 mg/dL) impaired fasting glucose (IFG). Results: Of 1,637 participants, 27.2% had T2DM and 59.3% had IFG and/or impaired glucose tolerance (IGT). The mean age was 55.0 ± 8.1 years and the mean BMI was 26.3 ± 2.7 kg/m2. Based on FPG criteria, 515 (31.4%) and 352 (21.5%) subjects were classified as having stage 1 and stage 2 IFG, respectively. The 19.0% of stage 1 and 43.5% of stage 2 subjects showed 2hr PG levels in the diabetic range. Even for those in the normal FPG range, 63 (9.5%) participants showed a 2hr PG level of ≥ 200 mg/dL. Of 446 subjects with newly-diagnosed diabetes, 340 (76.2%) showed FPG levels < 126 mg/dL. Conclusions: The oral glucose tolerance test should be actively considered for Korean adults who are overweight or obese with the IFG range (FPG, 100 to 125 mg/ dL) to allow for early detection of diabetes and prompt intervention.
Abstract
Background/Aims: We examined the concordance rate among fasting plasma glucose (FPG), 2-hour post-challenge glucose (2hr PG), and hemoglobin A1c (HbA1c) in the diagnosis of diabetes in a population with a high-risk for type 2 diabetes mellitus (T2DM) in Korea. Methods: Among the participants from the Korean Diabetes Prevention Study, individuals with FPG ≥ 100 mg/dL, body mass index (BMI) ≥ 23.0 kg/m2, and no previous history of T2DM were consecutively enrolled after a 75 g glucose tolerance test. We analyzed the differences in the clinical characteristics in subjects with stage 1 (FPG, 100 to 109 mg/dL) and stage 2 (FPG, 110 to 125 mg/dL) impaired fasting glucose (IFG). Results: Of 1,637 participants, 27.2% had T2DM and 59.3% had IFG and/or impaired glucose tolerance (IGT). The mean age was 55.0 ± 8.1 years and the mean BMI was 26.3 ± 2.7 kg/m2. Based on FPG criteria, 515 (31.4%) and 352 (21.5%) subjects were classified as having stage 1 and stage 2 IFG, respectively. The 19.0% of stage 1 and 43.5% of stage 2 subjects showed 2hr PG levels in the diabetic range. Even for those in the normal FPG range, 63 (9.5%) participants showed a 2hr PG level of ≥ 200 mg/dL. Of 446 subjects with newly-diagnosed diabetes, 340 (76.2%) showed FPG levels < 126 mg/dL. Conclusions: The oral glucose tolerance test should be actively considered for Korean adults who are overweight or obese with the IFG range (FPG, 100 to 125 mg/ dL) to allow for early detection of diabetes and prompt intervention.
참고문헌 (29)
- "Korean diabetes fact sheet 2018" (2018)[URL]
- Knowler WC, "Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin", N Engl J Med, 346, pp.393~403 (2002)
- de Vegt F, "Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population : the Hoorn Study", JAMA, 285, pp.2109~2113 (2001)
- Bergman M, "Diabetes prevention: global health policy and perspectives from the ground", Diabetes Manag(Lond), 2, pp.309~321 (2012)
- "Report of the expert committee on the diagnosis and classification of diabetes mellitus", Diabetes Care, 20, pp.1183~1197 (1997)
- Parappil A, "Diagnostic criteria for diabetes revisited : making use of combined criteria", BMC Endocr Disord, 2, pp.1~ (2002)
- Narayan KM, "Targeting people with pre-diabetes", BMJ, 325, pp.403~404 (2002)
- Perreault L, "Impaired fasting glucose with or without impaired glucose tolerance: progressive or parallel states of prediabetes?", Am J Physiol Endocrinol Metab, 295, pp.E428~E435 (2008)
- Janghorbani M, "Comparison of fasting glucose with post-load glucose values and glycated hemoglobin for prediction of type 2 diabetes : the Isfahan diabetes prevention study", Rev Diabet Stud, 6, pp.117~123 (2009)
- Bao C, "Optimal cut-off points of fasting plasma glucose for two-step strategy in estimating prevalence and screening undiagnosed diabetes and pre-diabetes in Harbin, China", PLoS One, 10, pp.e0119510~ (2015)
- "Committee of Clinical Practice Guideline of Korean Diabetes Association. 2015 Treatment guideline for diabetes" (2011)[URL]
- Cha SA, "Community-based randomized controlled trial of diabetes prevention study for high-risk individuals of type 2 diabetes : lifestyle intervention using web-based system", BMC Public Health, 17, pp.387~395 (2017)
- 이상열, "Hospital-Based Korean Diabetes Prevention Study: A Prospective, Multi-Center, Randomized, Open-Label Controlled Study", Diabetes and Metabolism Journal, 43(1), pp.49~58 (2019), 대한당뇨병학회[DOI]
- American Diabetes Association, "2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2018", Diabetes Care, 41(Suppl 1), pp.S13~S27 (2018)
- Huang Y, "Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis", BMJ, 355, pp.i5953~ (2016)
- Park C, "Fasting glucose level and the risk of incident atherosclerotic cardiovascular diseases", Diabetes Care, 36, pp.1988~1993 (2013)
- Diabetes Prevention Program(DPP)Research Group, "The Diabetes Prevention Program(DPP) : description of lifestyle intervention", Diabetes Care, 25, pp.2165~2171 (2002)
- Diabetes Prevention Program Research Group, "10-Year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study", Lancet, 374, pp.1677~1686 (2009)
- Lindstrom J, "Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention : follow-up of the Finnish Diabetes Prevention Study", Lancet, 368, pp.1673~1679 (2006)
- DeJesus RS, "Incidence rate of prediabetes progression to diabetes : modeling an optimum target group for intervention", Popul Health Manag, 20, pp.216~223 (2017)
- 서미혜, "Prevalence of Obesity and Incidence of Obesity-Related Comorbidities in Koreans Based on National Health Insurance Service Health Checkup Data 2006–2015", Journal of Obesity & Metabolic Syndrome, 27(1), pp.46~52 (2018), 대한비만학회
- Lee YH, "A simple screening score for diabetes for the Korean population : development, validation, and comparison with other scores", Diabetes Care, 35, pp.1723~1730 (2012)
- Haneda M, "Japanese clinical practice guideline for diabetes 2016", Diabetol Int, 9, pp.1~45 (2018)
- DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group, "Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data", BMJ, 317, pp.371~375 (1998)
- Tai ES, "Lowering the criterion for impaired fasting glucose : impact on disease prevalence and associated risk of diabetes and ischemic heart disease", Diabetes Care, 27, pp.1728~1734 (2004)
- Tuomilehto J, "Point : a glucose tolerance test is important for clinical practice", Diabetes Care, 25, pp.1880~1882 (2002)
- Unwin N, "Impaired glucose tolerance and impaired fasting glycaemia : the current status on definition and intervention", Diabet Med, 19, pp.708~723 (2002)
- 김미경, "2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea", Diabetes and Metabolism Journal, 43(4), pp.398~406 (2019), 대한당뇨병학회[DOI]
- Oh JY, "A report on the diagnosis of intermediate hyperglycemia in Korea : a pooled analysis of four community-based cohort studies", Diabetes Res Clin Pract, 80, pp.463~468 (2008)